Rchr
J-GLOBAL ID：201801002832956822
Update date: Sep. 11, 2024
Ohki Kentaro
オオキ ケンタロウ | Ohki Kentaro
Affiliation and department：
Research field (1)：
Fetal medicine/Pediatrics
Research theme for competitive and other funds (11)：
- 2021 - 2025 Analyis of molecular characteristics of refractory/relapsed lymphoblastic lymphoma of children and young adult.
- 2018 - 2021 The elucidation of the genetic abnormalities of leukemia/lymphoma indicating characteristic cell marker and the establishment of new disease entity
- 2014 - 2017 The study of the prognostic factor search in pediatric acute myeloid leukemia using the next generation sequencing and MLPA method
- 2014 - 2017 Next generation sequencing analysis of transient abnormal myelopoiesis and acute megakaryoblastic leukemia in Down syndrome
- 2013 - 2016 Clonal evolution analyses between relapse and diagnosis samples in pediatric acute myeloid leukemia by next generation sequencer
- 2013 - 2016 Molecular analysis of pediatric myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML) by next generation sequencer
- 2012 - 2015 Molecular analyses and the development of targeting therapy of pediatric acute myeloid leukemia using next generation sequencer
- 2011 - 2013 Integrated molecular analyses of T cell acute lymphoblastic leukemia using SNP and methyration arrays
- 2010 - 2012 Genome wide analysis of imprinting gene in pediatric solid tumor
- 2010 - 2012 Whole genome and epigenome analysis of Juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome
- 2009 - 2011 Molecular anlysis and development of targeting therapy in pediatric solid tumors by use of whole genomic and epigenomic resolution
Show all
Papers (131)：
-
Shota Kato, Shin-Ichi Tsujimoto, Jun Matsubayashi, Shotaro Iwamoto, Hidefumi Hiramatsu, Yusuke Okuno, Tatsuya Kamitori, Kentaro Ohki, Takao Deguchi, Nobutaka Kiyokawa, et al. Adverse prognostic impact of <i>KIT</i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with <i>RUNX1::RUNX1T1</i>. Haematologica. 2024
-
Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda, Tomoko Kawai, Kentaro Ohki, Yusuke Hara, Genki Yamato, Reo Tanoshima, Daisuke Tomizawa, Akira Shimada, et al. High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial. Pediatric blood & cancer. 2024. e31151
-
Masahiro Sekimizu, Fukano R, Koga Y, Mitsui T, Fujita N, Mori T, Hori D, Tanaka M, Ohki K, Iwafuchi H, et al. Rituximab-combined Anthracycline-free Chemotherapy in Newly Diagnosed Paediatric and Adolescent Patients with Non-high-risk Aggressive Mature B Cell Lymphoma: Protocol for a Single-arm, Open-label, Multicentre, Phase II Study (The Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20). BMJ Open. 2024
-
Tetsuya Mori, Tomoo Osumi, Akiko Kada, Kentaro Ohki, Yuhki Koga, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Takeshi Mori, Akiko M Saito, et al. Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial. European journal of haematology. 2023
-
Mayumi Hangai, Takahisa Kawaguchi, Masatoshi Takagi, Keitaro Matsuo, Soyoung Jeon, Charleston W K Chiang, Andrew T Dewan, Adam J De Smith, Toshihiko Imamura, Yasuhiro Okamoto, et al. Genome-wide assessment of genetic risk loci for childhood acute lymphoblastic leukemia in Japanese patients. Haematologica. 2023
ｍore...
MISC (142)：
-
Genki Yamato, Tomoko Kawai, Norio Shiba, Yusuke Hara, Kentaro Ohki, Taeko Kaburagi, Etsuko Ishikita, Hirohide Kawasaki, Kenichi Yoshida, Yuichi Shiraishi, et al. Prognosis of Pediatric Acute Myeloid Leukemia with KMT2A-MLLT3 According to DNA Methylation Patterns: Jccg JPLSG AML-05 Study. BLOOD. 2022. 140. 9134-9135
-
石北悦子, 鏑木多映子, 大和玄季, 川島淳, 原勇介, 飯島真由子, 奥野はるな, 平戸純子, 渡部悟, 大木健太郎, et al. Isolated central nervous system relapse in acute monocytic leukemia diagnosed by FISH and cell marker analysis of cerebrospinal fluid cells. 日本小児血液・がん学会雑誌(Web). 2022. 59. 2
-
Ryota Shirai, Tomoo Osumi, Keita Terashima, Chikako Kiyotani, Meri Uchiyama, Shinichi Tsujimoto, Masanori Yoshida, Kaoru Yoshida, Toru Uchiyama, Daisuke Tomizawa, et al. PREVALENCE OF GERMLINE VARIANTS IN SMARCB1 INCLUDING SOMATIC MOSAICISM IN AT/RT AND OTHER RHABDOID TUMORS. NEURO-ONCOLOGY. 2020. 22. 277-278
-
小林純, 小林純, 小森一寿, 徳竹由美, 松澤悠, 久保田紀子, 久保田紀子, 清河信敬, 大木健太郎, 出口隆生, et al. MEF2D遺伝子再構成を伴う小児B細胞性急性リンパ性白血病の一例. 日本検査血液学会雑誌. 2020. 21
-
森健, 森健, 三井哲夫, 三井哲夫, 角南勝介, 関水匡大, 関水匡大, 大木健太郎, 大木健太郎, 大隅朋生, et al. Poor outcome for children and adolescents with relapsed or refractory lymphoblastic lymphoma:retrospective analysis between 2005 and 2016 in Japan. 日本造血細胞移植学会総会プログラム・抄録集. 2020. 42nd
ｍore...
Return to Previous Page
